期刊文献+

川崎病患儿并发冠状动脉病变的危险因素分析 被引量:20

Risk factors for coronary artery lesions in children with Kawasaki disease
原文传递
导出
摘要 目的探讨川崎病(KD)并发冠状动脉病变(CAL)的危险因素。方法收集2006年1月至2012年1月间诊断为KD的527例患儿的临床资料,对15个可能与CAL发生有关的因素进行单因素和多因素logistic回归分析。结果单因素分析显示,患儿年龄、性别、KD类型、大剂量丙种球蛋白(IVIG)治疗起始时间、对IVIG治疗的反应、使用糖皮质激素、发热持续时间及C反应蛋白等因素在合并和未合并CAL两组患儿中差异有统计学意义(P<0.05)。进一步多因素logistic回归分析显示,年龄<1岁和>8岁、男性、非典型KD、IVIG治疗开始于发热后10 d以上、对IVIG治疗无反应、发热持续时间>10 d为CAL发生的独立危险因素(OR分别为2.076、1.890、1.972、1.426、3.251、2.301、1.694,均P<0.05),IVIG治疗起始时间<5 d为CAL的保护性因素(OR=0.248,P<0.05)。结论 KD患儿CAL的发生与多种因素有关,年龄(<1岁和>8岁)、男性、非典型KD、IVIG治疗起始时间较晚、对IVIG治疗无反应、发热持续时间较长是CAL发生的独立危险因素。 Objective To study risk factors for the development of coronary artery lesions(CAL) in children with Kawasaki disease(KD).Methods The clinical data of 527 children with KD between January 2006 and January 2009 were retrospectively reviewed.A total of 15 potential factors associated with occurrence of CAL were evaluated by univariate analysis and multivariate logistic regression analysis.Results The univariate analysis showed that age,gender,KD type,starting time of intravenous immunoglobulin(IVIG) treatment,response to IVIG treatment,additional treatment with corticosteroids,duration of fever and serum C-reactive protein level were significantly different between patients with and without CAL(P〈0.05).Multivariate logistic regression analysis showed that an age of less than 1 year(OR=2.076,P〈0.05) or greater than 8 years(OR=1.890,P〈0.05),male sex(OR=1.972,P〈0.05),incomplete KD(OR=1.426,P〈0.05),delayed starting time of IVIG treatment(10 days after onset)(OR=3.251,P〈0.05),no response to IVIG(OR=2.301,P〈0.05) and fever duration of more than 10 days(OR=1.694,P〈0.05) were independent risk factors for the development of CAL,whereas early starting time of IVIG treatment(before 5 days after onset) was a protective factor(OR=0.248,P〈0.05).Conclusions The occurrence of CAL is associated with many factors in children with KD.Age of less than 1 year or greater than 8 years,male sex,incomplete KD,delayed IVIG treatment after onset,no response to IVIG treatment and prolonged fever duration have been identified as risk factors for the development of CAL.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2012年第12期938-941,共4页 Chinese Journal of Contemporary Pediatrics
关键词 川崎病 冠状动脉病变 静脉注射免疫球蛋白 糖皮质激素 儿童 Kawasaki disease Coronary artery lesions Intravenous immunoglobulin Corticosteroid Child
  • 相关文献

参考文献19

  • 1Coustasse A, Larry J, Lee D. Can Kawasaki disease be managed? [J]. Perm J, 2012, 16(2) : 70-72.
  • 2Alexopoulos A, Vekiou A, Lycopoulou L, Tavena A, Lagona E, Kakourou T. Kawasaki disease in Greek children: a retrospective study[J]. J Eur Acad Dermatol Venereol, 2012, doi: 10. 1111/ j. 1468-3083. 2012. 04488. x. [ Epub ahead of print].
  • 3Daniels LB, Tjajadi MS, Walford HH, Jimenez-Fernandez S, Tro- fimenko V, Fick DB Jr, et al. Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia[ J]. Circulation, 2012, 125(20) : 2447-2453.
  • 4Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Dis-ease, Council on Cardiovascular Disease in the Young, American Heart Association [ J ]. Circulation, 2004, 110 ( 17 ) : 2747-2771.
  • 5McMorrow Tuohy AM, Tani LY, Cetta F, Lewin MB, Eidem BW, Van Buren P, et al. How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease? [ J]. Am J Cardiol, 2001, 88(3) : 328-330.
  • 6Scott JS, Ettedgui JA, Neches WH. Cost-effective use of echocar- diography in children with Kawasaki disease [ J ]. Pediatrics, 1999, 104(5): e57.
  • 7Callinan LS, Tabnak F, Holman RC, Maddox RA, Kim J J, Schon- berger LB, et al. Kawasaki syndrome and factors associated with coronary artery abnormalities in california[ J]. Pediatr Infect Dis J, 2012, 31(9) : 894-898.
  • 8Belay ED, Maddox RA, Holman RC, Cures AT, Ballab K, Sehon- berger LB. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003[J]. Pediatr Infect Dis J, 2006, 25(3): 245-249.
  • 9Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in in- fants less than one year of age[J]. J Pediatr, 1995, 126(4) : 524-529.
  • 10Cai Z, Zuo R, Liu Y. Characteristics of Kawasaki disease in older children[J]. Clin Pediatr (Phila), 2011,50( 10): 952-956.

二级参考文献40

  • 1杜忠东,张永兰,赵地,杜军保,鲁珊,衣京梅,侯安存,周忠蜀,丁国芳,林瑶,刘冲,北京小儿川崎病流行病学调查协作组.静脉丙种球蛋白无反应性川崎病的治疗及危险因素分析[J].中国实用儿科杂志,2006,21(10):738-741. 被引量:89
  • 2张谦慎,董国庆.同胞共患川崎病三例[J].中国优生与遗传杂志,2007,15(2):109-109. 被引量:2
  • 3Durongpisitkul K,Soongswang J,Laohaprasitiporn D,Nana A,Prachuabmoh C,Kangkagate C.Immunoglobulin failure and re-treatment in Kawasaki disease[J].Pediatr Cardiol,2003,24(2):145-148.
  • 4Sittiwangkul R,Pongprot Y,Silvilairat S,Phornphutkul C.Man-agement and outcome of intravenous gammaglobulin-resistant Ka-wasaki disease[J].Singapore Med J,2006,47(9):780-784.
  • 5Brogan PA,Bose A,Burgner D,Shingadia D,Tulloh R,Michie C,et al.Kawasaki disease:an evidence based approach to diag-nosis,treatment,and proposals for future research[J].Arch Dis Child,2002,86(4):286-290.
  • 6Minami T,Suzuki H,Takeuchi T,Uemura S,Sugatani J,Y0-shikawa N.A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treat-ment in Kawasaki disease[J].J Pediatr,2005,147(1):78-83.
  • 7Ashouri N,Takahashi M,Dorey F,Mason W.Risk factors for nonresponse to therapy in Kawasaki disease[J].J Pediatr,2008,153(3):365-368.
  • 8Tremoulet AH,Best BM,Song S,Wang S,Corinaldesi E,Eichenfield JR,et al.Resistance to intravenous immunoglobulin in childrenwithKawasaki disease[J].J Pediatr,2008,153(1):117.121.
  • 9Uehara R,Belay ED,Maddox RA,Holman RC,Nakamura Y,Yashiro M,et al.Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan[J].Pediatr Infect Dis J,2008,27(2):155-160.
  • 10Okada K,Hara J,Maki I,Miki K,Matsuzaki K,Matsuoka T,et al.Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease[J].Eur J Pediatr,2009,168(2):181-185.

共引文献7

同被引文献305

引证文献20

二级引证文献194

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部